lorazepam has been researched along with Acute Disease in 63 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intravenous lorazepam is considered the drug of first choice for control of acute convulsive seizures." | 9.15 | Intranasal versus intravenous lorazepam for control of acute seizures in children: a randomized open-label study. ( Arya, R; Gulati, S; Kabra, M; Kalra, V; Sahu, JK, 2011) |
| "We conducted a prospective double-blind study of accelerated dose titration of olanzapine in the treatment of newly admitted acutely agitated patients with schizophrenia." | 9.11 | Efficacy of accelerated dose titration of olanzapine with adjunctive lorazepam to treat acute agitation in schizophrenia. ( Ahl, J; Kinon, BJ; McMullen, E; Rotelli, MD, 2004) |
| "This double-blind study investigated the efficacy and safety of rapid-acting intramuscular olanzapine in treating agitation associated with Alzheimer's disease and/or vascular dementia." | 9.10 | Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia. ( Beasley, CM; Beckett, LM; Breier, A; David, SR; Feldman, PD; Jones, B; Meehan, KM; Mintzer, JE; Nisivoccia, JR; Wang, H, 2002) |
| "In view of reports in the literature that catatonia responds well to benzodiazepines, and the possible association between catatonia and seizure disorders, an open prospective study was conducted to explore the possibility that catatonia may be successfully treated with carbamazepine." | 9.09 | Catatonia: an open prospective series with carbamazepine. ( Jordaan, GP; Kritzinger, PR, 2001) |
| "A short-cut review was carried out to determine whether intranasal lorazepam was as effective as intravenous lorazepam in the control of seizures in children." | 8.89 | Best BETs from the Manchester Royal Infirmary. BET 1: intranasal lorazepam is an acceptable alternative to intravenous lorazepam in the control of acute seizures in children. ( Allan, A; Cullen, J, 2013) |
| "Lorazepam was also given as needed (total dose, < or =4 mg/d) but not in place of a study drug dose increase." | 6.73 | Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia. ( Chen, L; Kinon, BJ; Kollack-Walker, S; Sniadecki, J; Stauffer, VL, 2008) |
| "Intravenous lorazepam is considered the drug of first choice for control of acute convulsive seizures." | 5.15 | Intranasal versus intravenous lorazepam for control of acute seizures in children: a randomized open-label study. ( Arya, R; Gulati, S; Kabra, M; Kalra, V; Sahu, JK, 2011) |
| "Aripiprazole was associated with beneficial effects on mood in patients with bipolar depression, and appears well tolerated with very small changes in mean body weight." | 5.13 | Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial. ( Bria, P; Janiri, L; Mazza, M; Pecora, RD; Squillacioti, MR, 2008) |
| "We conducted a prospective double-blind study of accelerated dose titration of olanzapine in the treatment of newly admitted acutely agitated patients with schizophrenia." | 5.11 | Efficacy of accelerated dose titration of olanzapine with adjunctive lorazepam to treat acute agitation in schizophrenia. ( Ahl, J; Kinon, BJ; McMullen, E; Rotelli, MD, 2004) |
| "This double-blind study investigated the efficacy and safety of rapid-acting intramuscular olanzapine in treating agitation associated with Alzheimer's disease and/or vascular dementia." | 5.10 | Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia. ( Beasley, CM; Beckett, LM; Breier, A; David, SR; Feldman, PD; Jones, B; Meehan, KM; Mintzer, JE; Nisivoccia, JR; Wang, H, 2002) |
| "In view of reports in the literature that catatonia responds well to benzodiazepines, and the possible association between catatonia and seizure disorders, an open prospective study was conducted to explore the possibility that catatonia may be successfully treated with carbamazepine." | 5.09 | Catatonia: an open prospective series with carbamazepine. ( Jordaan, GP; Kritzinger, PR, 2001) |
| "Nineteen patients with bipolar disorder, manic phase, received divalproex sodium 20 mg/kg/day in divided dosages for 5 days, without other psychotropic agents except lorazepam up to 4 mg/day." | 5.07 | Valproate oral loading in the treatment of acute mania. ( Bennett, JA; Keck, PE; McElroy, SL; Tugrul, KC, 1993) |
| "In a double-blind, prospective study, 2 mg of intramuscular lorazepam and 5 mg of intramuscular haloperidol were equally effective in controlling aggression, agitation, and assaultive behavior." | 5.07 | Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior. ( Flowers, E; Glassman, R; Miyawaki, E; Rood, L; Salzman, C; Solomon, D; Thayer, S, 1991) |
| "A short-cut review was carried out to determine whether intranasal lorazepam was as effective as intravenous lorazepam in the control of seizures in children." | 4.89 | Best BETs from the Manchester Royal Infirmary. BET 1: intranasal lorazepam is an acceptable alternative to intravenous lorazepam in the control of acute seizures in children. ( Allan, A; Cullen, J, 2013) |
| " Our study aims to assess if administering lorazepam, for convulsive seizures <5 min, causes vital instability." | 3.96 | Lorazepam timing for acute convulsive seizure control (LoTASC). ( Gopal, M; Greene-Chandos, D; Hamed, M; Hussein, O; Kamdar, HA; Peters, E; Sawalha, K; Shanmugam, K; Smetana, KS; Thakur, G; Yasin, R, 2020) |
| "Lorazepam, dexamethasone and high-dose metoclopramide were given to 54 patients to prevent emesis induced by cisplatin (50-120 mg/m2) on day 1, while prochlorperazine and dexamethasone were administered on days 2 and 3 for control of delayed emesis." | 3.68 | Acute and delayed emesis after cisplatin-based regimen: description and prevention. ( Beaulieu, R; Courchesne, Y; Latreille, J; Letendre, F; Lorange, A; Louvet, C; Monte, M; Neemeh, JA; Pretty, HM, 1991) |
| "For diazepam group it was 84." | 2.77 | Intravenous diazepam, midazolam and lorazepam in acute seizure control. ( Gathwala, G; Goel, M; Mittal, K; Singh, J, 2012) |
| "Lorazepam was also given as needed (total dose, < or =4 mg/d) but not in place of a study drug dose increase." | 2.73 | Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia. ( Chen, L; Kinon, BJ; Kollack-Walker, S; Sniadecki, J; Stauffer, VL, 2008) |
| " Aripiprazole was dosed flexibly up to a maximum of 30 mg daily, based on tolerability and efficacy." | 2.73 | A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression. ( Chriki, LS; Dunn, RT; Filkowski, MM; Ghaemi, SN; Stan, VA, 2008) |
| "To compare oral risperidone and intramuscular (IM) haloperidol, both in combination with IM lorazepam, in the management of acute agitation and psychosis in the medical emergency department." | 2.72 | Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial. ( Currier, GW; McMullan, JT; Veser, BD; Veser, FH; Zealberg, J, 2006) |
| " Mean score improvements at 30, 60, and 120 minutes after dosing were significant at each timepoint in both groups (p <." | 2.71 | Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam. ( Bossie, CA; Chou, JC; Currier, GW; Feifel, D; Gharabawi, GM; Mahmoud, RA; Turkoz, I, 2004) |
| " Mean daily lorazepam dosage was 0." | 2.67 | Haloperidol and lorazepam combined: clinical effects and drug plasma levels in the treatment of acute schizophrenic psychosis. ( Gaertner, HJ; Mahal, A; Stevens, A; Stevens, I, 1992) |
| " Serum valproate concentrations were measured three times weekly; an unblinded investigator then adjusted dosage to produce serum concentrations between 50 and 100 mg/L." | 2.67 | Valproate in the treatment of acute mania. A placebo-controlled study. ( Hudson, JI; Keck, PE; McElroy, SL; Pope, HG, 1991) |
| "Treatment with lorazepam produced marked improvement in symptomatology, while treatment with clonazepam failed to demonstrate a significant therapeutic effect." | 2.67 | Double-blind comparison of the effects of clonazepam and lorazepam in acute mania. ( Bradwejn, J; Koszycki, D; Meterissian, G; Shriqui, C, 1990) |
| " Ironically, chronic use of cannabis can result in paradoxical effects, including a condition known as cannabinoid hyperemesis syndrome." | 2.61 | Cannabinoid hyperemesis syndrome: An unrecognized cause of nausea and vomiting. ( Forest, CP; Smith, TN; Walsh, A, 2019) |
| "Most seizure emergencies occur outside of the hospital, and there is a need for treatment interventions that can be administered quickly and safely by nonclinical caregivers." | 2.52 | Intranasal therapies for acute seizures. ( Kälviäinen, R, 2015) |
| "When haloperidol and midazolam were compared with olanzapine, there was some evidence the combination was superior in terms of improvement, sedation and behaviour." | 2.49 | Benzodiazepines for psychosis-induced aggression or agitation. ( Beck, A; Gillies, D; Rathbone, J; Sampson, S, 2013) |
| " In several countries, clinicians often use benzodiazepines (either alone or in combination with antipsychotics) for this outcome." | 2.43 | Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis. ( Beck, A; Gillies, D; McCloud, A; Rathbone, J, 2005) |
| "Drug-induced delirium is a common matter in the elderly and anticholinergics, together with a number of different drugs, may significantly contribute to the delirium onset, especially in demented people." | 1.34 | Anticholinergic drug-induced delirium in an elderly Alzheimer's dementia patient. ( Cotroneo, A; De Fazio, P; De Fazio, S; De Sarro, G; Gallelli, L; Gareri, P; Lacava, R, 2007) |
| "Oral treatment with risperidone and lorazepam appears to be a tolerable and comparable alternative to intramuscular haloperidol and lorazepam for short-term treatment of agitated psychosis in patients who accept oral medications." | 1.31 | Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation. ( Currier, GW; Simpson, GM, 2001) |
| " A full pharmacokinetic time profile of lithium was obtained." | 1.31 | Bayesian pharmacokinetics of lithium after an acute self-intoxication and subsequent haemodialysis: a case report. ( Beijnen, JH; Kerbusch, T; Mathôt, RA; Meesters, EW; Otten, HM; Schellens, JH; van Kan, HJ, 2002) |
| "A case of Gilles de la Tourette's syndrome (TS) is described, in which a state of akinesia developed during an attempt to withdraw lorazepam by diazepam substitution." | 1.28 | Gilles de la Tourette's syndrome. Amelioration following acute akinesia during lorazepam withdrawal. ( Peet, M; Wright, S, 1989) |
| "Experimental vasogenic cerebral edema was created in rabbits with a cold-induced left occipital cortical lesions." | 1.26 | Acute therapeutic modalities for experimental vasogenic edema. ( Harbaugh, RD; James, HE; Laurin, R; Marshall, LF; Shapiro, HM, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (15.87) | 18.7374 |
| 1990's | 15 (23.81) | 18.2507 |
| 2000's | 25 (39.68) | 29.6817 |
| 2010's | 11 (17.46) | 24.3611 |
| 2020's | 2 (3.17) | 2.80 |
| Authors | Studies |
|---|---|
| Law, J | 1 |
| Cardy, V | 1 |
| Kamdar, HA | 1 |
| Hamed, M | 1 |
| Smetana, KS | 1 |
| Shanmugam, K | 1 |
| Peters, E | 1 |
| Yasin, R | 1 |
| Thakur, G | 1 |
| Gopal, M | 1 |
| Sawalha, K | 1 |
| Greene-Chandos, D | 1 |
| Hussein, O | 1 |
| Smith, TN | 1 |
| Walsh, A | 1 |
| Forest, CP | 1 |
| Morrison, M | 1 |
| Udeh, E | 1 |
| Burak, M | 1 |
| Gillies, D | 3 |
| Sampson, S | 1 |
| Beck, A | 2 |
| Rathbone, J | 2 |
| Allan, A | 1 |
| Cullen, J | 1 |
| Cappiello, JL | 1 |
| Hocker, MB | 1 |
| Jørgensen, A | 1 |
| Hansen, BS | 1 |
| Stanislaus, S | 1 |
| Düring, S | 1 |
| Jørgensen, MB | 1 |
| Pinborg, LH | 1 |
| Kondziella, D | 1 |
| Kälviäinen, R | 1 |
| Peterson, E | 1 |
| Stoebner, A | 1 |
| Weatherill, J | 1 |
| Kutscher, E | 1 |
| Kinon, BJ | 2 |
| Stauffer, VL | 1 |
| Kollack-Walker, S | 1 |
| Chen, L | 1 |
| Sniadecki, J | 1 |
| Mazza, M | 1 |
| Squillacioti, MR | 1 |
| Pecora, RD | 1 |
| Janiri, L | 1 |
| Bria, P | 1 |
| Citrome, L | 1 |
| Zilles, D | 1 |
| Hasan, A | 1 |
| Gruber, O | 1 |
| Degner, D | 1 |
| Arya, R | 1 |
| Gulati, S | 1 |
| Kabra, M | 1 |
| Sahu, JK | 1 |
| Kalra, V | 1 |
| Lagae, L | 1 |
| Gathwala, G | 1 |
| Goel, M | 1 |
| Singh, J | 1 |
| Mittal, K | 1 |
| Honderick, T | 1 |
| Williams, D | 1 |
| Seaberg, D | 1 |
| Wears, R | 1 |
| Wheless, JW | 1 |
| Sinha, PK | 1 |
| Ambesh, SP | 1 |
| Sielk, M | 1 |
| Currier, GW | 3 |
| Chou, JC | 1 |
| Feifel, D | 1 |
| Bossie, CA | 1 |
| Turkoz, I | 1 |
| Mahmoud, RA | 1 |
| Gharabawi, GM | 1 |
| Ahl, J | 1 |
| Rotelli, MD | 1 |
| McMullen, E | 1 |
| Lejeune, J | 1 |
| Larmo, I | 1 |
| Chrzanowski, W | 1 |
| Witte, R | 1 |
| Karavatos, A | 1 |
| Schreiner, A | 1 |
| Lex, A | 1 |
| Medori, R | 1 |
| McCloud, A | 1 |
| Srihari, VH | 1 |
| Lee, TS | 1 |
| Rohrbaugh, RM | 1 |
| D'Souza, DC | 1 |
| Veser, FH | 1 |
| Veser, BD | 1 |
| McMullan, JT | 1 |
| Zealberg, J | 1 |
| von Wrede, R | 1 |
| Gareri, P | 1 |
| De Fazio, P | 1 |
| Cotroneo, A | 1 |
| Lacava, R | 1 |
| Gallelli, L | 1 |
| De Fazio, S | 1 |
| De Sarro, G | 1 |
| Zimbroff, DL | 1 |
| Marcus, RN | 1 |
| Manos, G | 1 |
| Stock, E | 1 |
| McQuade, RD | 1 |
| Auby, P | 1 |
| Oren, DA | 1 |
| Battaglia, J | 1 |
| Dunn, RT | 1 |
| Stan, VA | 1 |
| Chriki, LS | 1 |
| Filkowski, MM | 1 |
| Ghaemi, SN | 1 |
| Solomon, J | 1 |
| Rouck, LA | 1 |
| Koepke, HH | 1 |
| Garnier, R | 1 |
| Medernach, C | 1 |
| Harbach, S | 1 |
| Fournier, E | 1 |
| Jaspert, A | 1 |
| Ebert, D | 1 |
| Keck, PE | 2 |
| McElroy, SL | 2 |
| Tugrul, KC | 1 |
| Bennett, JA | 1 |
| Northoff, G | 3 |
| Wenke, J | 2 |
| Pflug, B | 2 |
| Demisch, L | 1 |
| Eckert, J | 2 |
| Gille, B | 1 |
| Kramer, MS | 1 |
| Last, B | 1 |
| Getson, A | 1 |
| Reines, SA | 1 |
| Hillard, JR | 1 |
| Braus, DF | 1 |
| Sartorius, A | 1 |
| Khoram-Sefat, D | 1 |
| Russ, M | 1 |
| Herrig, M | 1 |
| Leschinger, A | 1 |
| Bogerts, B | 1 |
| Henn, FA | 1 |
| Hughes, DH | 1 |
| Geffen, J | 1 |
| Tsoh, JM | 1 |
| Leung, HC | 1 |
| Ungvari, GS | 1 |
| Lee, DT | 1 |
| Simpson, GM | 1 |
| Kritzinger, PR | 1 |
| Jordaan, GP | 1 |
| Meehan, KM | 1 |
| Wang, H | 1 |
| David, SR | 1 |
| Nisivoccia, JR | 1 |
| Jones, B | 1 |
| Beasley, CM | 1 |
| Feldman, PD | 1 |
| Mintzer, JE | 1 |
| Beckett, LM | 1 |
| Breier, A | 1 |
| Kerbusch, T | 1 |
| Mathôt, RA | 1 |
| Otten, HM | 1 |
| Meesters, EW | 1 |
| van Kan, HJ | 1 |
| Schellens, JH | 1 |
| Beijnen, JH | 1 |
| Gomez-Lozano, P | 1 |
| Kraus, JW | 1 |
| Desmond, PV | 1 |
| Marshall, JP | 1 |
| Johnson, RF | 1 |
| Schenker, S | 1 |
| Wilkinson, GR | 1 |
| Hosein, IN | 1 |
| de Freitas, R | 1 |
| Beaubrun, MH | 1 |
| Harbaugh, RD | 1 |
| James, HE | 1 |
| Marshall, LF | 1 |
| Shapiro, HM | 1 |
| Laurin, R | 1 |
| Röschke, J | 1 |
| Stevens, A | 1 |
| Stevens, I | 1 |
| Mahal, A | 1 |
| Gaertner, HJ | 1 |
| Salzman, C | 1 |
| Solomon, D | 1 |
| Miyawaki, E | 1 |
| Glassman, R | 1 |
| Rood, L | 1 |
| Flowers, E | 1 |
| Thayer, S | 1 |
| Louvet, C | 1 |
| Lorange, A | 1 |
| Letendre, F | 1 |
| Beaulieu, R | 1 |
| Pretty, HM | 1 |
| Courchesne, Y | 1 |
| Neemeh, JA | 1 |
| Monte, M | 1 |
| Latreille, J | 1 |
| Pope, HG | 1 |
| Hudson, JI | 1 |
| Bradwejn, J | 1 |
| Shriqui, C | 1 |
| Koszycki, D | 1 |
| Meterissian, G | 1 |
| Stevens, CB | 1 |
| Wright, S | 1 |
| Peet, M | 1 |
| Chouinard, G | 1 |
| Dubin, WR | 1 |
| Lenox, RH | 1 |
| Modell, JG | 1 |
| Weiner, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Sub-dissociative Intranasal Ketamine Plus Standard Pain Therapy Versus Standard Pain Therapy in the Treatment of Pediatric Sickle Cell Disease Vasoocclusive Crises in Resource-limited Settings: a Multi-centered, Randomized, Controlled Trial[NCT02573714] | 160 participants (Anticipated) | Interventional | 2015-12-31 | Recruiting | |||
| Intra-Nasal vs. Intra-Venous Lorazepam for Control of Acute Seizures in Children: Prospective Open Labeled Randomized Equivalence Trial[NCT00735527] | Phase 3 | 140 participants (Anticipated) | Interventional | 2008-05-31 | Completed | ||
| Comparison of Oral Risperdal in Combination With Oral Lorazepam vs Standard Care Including Initial Conventional Neuroleptic IM Treatment, in Acute Schizophrenic Patients[NCT00249171] | Phase 4 | 226 participants (Actual) | Interventional | 2001-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 reviews available for lorazepam and Acute Disease
| Article | Year |
|---|---|
Cannabinoid hyperemesis syndrome: An unrecognized cause of nausea and vomiting.
Topics: Acute Disease; Antiemetics; Cannabinoids; Haloperidol; Humans; Lorazepam; Nausea; Syndrome; Vomiting | 2019 |
Benzodiazepines for psychosis-induced aggression or agitation.
Topics: Acute Disease; Aggression; Anti-Dyskinesia Agents; Antipsychotic Agents; Benzodiazepines; Drug Thera | 2013 |
Best BETs from the Manchester Royal Infirmary. BET 1: intranasal lorazepam is an acceptable alternative to intravenous lorazepam in the control of acute seizures in children.
Topics: Acute Disease; Administration, Intranasal; Anticonvulsants; Child, Preschool; Evidence-Based Emergen | 2013 |
Intranasal therapies for acute seizures.
Topics: Acute Disease; Administration, Intranasal; Anticonvulsants; Diazepam; Humans; Lorazepam; Midazolam; | 2015 |
Interventions for the treatment of acute agitation.
Topics: Acute Disease; Antipsychotic Agents; Humans; Hypnotics and Sedatives; Lorazepam; Psychomotor Agitati | 2007 |
Clinical practice: the treatment of acute convulsive seizures in children.
Topics: Acute Disease; Anticonvulsants; Benzodiazepines; Child; Diazepam; GABA Modulators; Humans; Lorazepam | 2011 |
Acute management of seizures in the syndromes of idiopathic generalized epilepsies.
Topics: Acute Disease; Adolescent; Adult; Anticonvulsants; Clonazepam; Comorbidity; Drug Administration Sche | 2003 |
[Problems with the treatment of schizophrenics in the doctor's office].
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Diazepam; Drug Therapy, Combination | 2003 |
Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Emergency Treatment | 2005 |
The treatment of acute agitation in schizophrenia.
Topics: Acute Disease; Antipsychotic Agents; Humans; Hypnotics and Sedatives; Lorazepam; Psychomotor Agitati | 2007 |
Emergency treatment of acute psychosis.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Clozapine; Decision Trees; Drug Administration | 1998 |
Acute psychopharmacological management of the aggressive psychotic patient.
Topics: Acute Disease; Aggression; Antipsychotic Agents; Dose-Response Relationship, Drug; Haloperidol; Huma | 1999 |
Rapid tranquilization: antipsychotics or benzodiazepines?
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Clonazepam; Drug Therapy, Combination; Humans; | 1988 |
23 trials available for lorazepam and Acute Disease
| Article | Year |
|---|---|
Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Be | 2008 |
Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Ag | 2008 |
Intranasal versus intravenous lorazepam for control of acute seizures in children: a randomized open-label study.
Topics: Acute Disease; Administration, Intranasal; Adolescent; Anticonvulsants; Child; Female; Humans; Injec | 2011 |
Intranasal versus intravenous lorazepam for control of acute seizures in children: a randomized open-label study.
Topics: Acute Disease; Administration, Intranasal; Adolescent; Anticonvulsants; Child; Female; Humans; Injec | 2011 |
Intranasal versus intravenous lorazepam for control of acute seizures in children: a randomized open-label study.
Topics: Acute Disease; Administration, Intranasal; Adolescent; Anticonvulsants; Child; Female; Humans; Injec | 2011 |
Intranasal versus intravenous lorazepam for control of acute seizures in children: a randomized open-label study.
Topics: Acute Disease; Administration, Intranasal; Adolescent; Anticonvulsants; Child; Female; Humans; Injec | 2011 |
Intravenous diazepam, midazolam and lorazepam in acute seizure control.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Diazepam; Female; Humans; Infant; Injections, In | 2012 |
A prospective, randomized, controlled trial of benzodiazepines and nitroglycerine or nitroglycerine alone in the treatment of cocaine-associated acute coronary syndromes.
Topics: Acute Disease; Adult; Angina Pectoris; Anti-Anxiety Agents; Cocaine; Drug Therapy, Combination; Fema | 2003 |
Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Cluster Analysis | 2004 |
Efficacy of accelerated dose titration of olanzapine with adjunctive lorazepam to treat acute agitation in schizophrenia.
Topics: Acute Disease; Administration, Oral; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepin | 2004 |
Oral risperidone plus oral lorazepam versus standard care with intramuscular conventional neuroleptics in the initial phase of treating individuals with acute psychosis.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Aggression; Antipsy | 2004 |
Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Anxiety Agents; Antipsychotic Agents; Double-Blind Meth | 2006 |
Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole.
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dis | 2007 |
A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression.
Topics: Acute Disease; Adolescent; Adult; Akathisia, Drug-Induced; Ambulatory Care; Antidepressive Agents; A | 2008 |
Double-blind comparison of lorazepam and chlordiazepoxide in the treatment of the acute alcohol abstinence syndrome.
Topics: Acute Disease; Adult; Aged; Chlordiazepoxide; Clinical Trials as Topic; Double-Blind Method; Drug Ad | 1983 |
Valproate oral loading in the treatment of acute mania.
Topics: Acute Disease; Administration, Oral; Adult; Bipolar Disorder; Drug Therapy, Combination; Female; Hos | 1993 |
Catatonia: short-term response to lorazepam and dopaminergic metabolism.
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Anxiety; Catatonia; Depressive Disorder; Dopamine; Dyskin | 1995 |
The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group.
Topics: Acute Disease; Adult; Antipsychotic Agents; Chloral Hydrate; Dopamine Antagonists; Double-Blind Meth | 1997 |
Catatonia: an open prospective series with carbamazepine.
Topics: Acute Disease; Adolescent; Adult; Anticonvulsants; Carbamazepine; Catatonia; Female; Humans; Lorazep | 2001 |
Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia.
Topics: Acute Disease; Aged; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Dementia; Double-Bl | 2002 |
Intravenous lorazepam in the acute anxiety crisis: a preliminary report on 60 cases.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as T | 1976 |
Haloperidol and lorazepam combined: clinical effects and drug plasma levels in the treatment of acute schizophrenic psychosis.
Topics: Acute Disease; Adult; Drug Therapy, Combination; Female; Haloperidol; Humans; Lorazepam; Male; Middl | 1992 |
Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior.
Topics: Acute Disease; Adult; Aggression; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combinati | 1991 |
Valproate in the treatment of acute mania. A placebo-controlled study.
Topics: Acute Disease; Adolescent; Adult; Aged; Bipolar Disorder; Double-Blind Method; Drug Administration S | 1991 |
Double-blind comparison of the effects of clonazepam and lorazepam in acute mania.
Topics: Acute Disease; Adult; Bipolar Disorder; Clonazepam; Double-Blind Method; Drug Therapy, Combination; | 1990 |
The use of benzodiazepines in the treatment of manic-depressive illness.
Topics: Acute Disease; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Basal Ga | 1988 |
27 other studies available for lorazepam and Acute Disease
| Article | Year |
|---|---|
Pharmacological Relief of Acute Urinary Retention in a Remote Environment.
Topics: Acute Disease; Humans; Lorazepam; Male; Tamsulosin; Treatment Outcome; Urinary Retention | 2023 |
Lorazepam timing for acute convulsive seizure control (LoTASC).
Topics: Acute Disease; Adult; Aged; Anticonvulsants; Benzodiazepines; Diazepam; Female; Humans; Lorazepam; M | 2020 |
Retrospective analysis of a gabapentin high dose taper compared to lorazepam in acute inpatient alcohol withdrawal.
Topics: Acute Disease; Adult; Alcoholism; Electronic Health Records; Endpoint Determination; Female; GABA Ag | 2019 |
Noninvasive ventilation in severe acute asthma.
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Asthma; Blood Gas Analysis; Humans; Lorazepam; Male; Noni | 2014 |
Anti-N-methyl-D-aspartate receptor encephalitis is an important differential diagnosis in acute psychiatric disease.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Anti-Anxiety Agents; Anti-N-Methyl-D-Aspa | 2015 |
Case of acute psychosis from herbal supplements.
Topics: Acute Disease; Adult; Antipsychotic Agents; Dietary Supplements; Female; Haloperidol; Humans; Loraze | 2008 |
Acute polydipsia and water intoxication in first episode schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Dibenzothiazepines; Female; Humans; Hypnotics and Sedati | 2010 |
Pre-operative psychosis following oral lorazepam.
Topics: Acute Disease; Aged; Anti-Anxiety Agents; Humans; Lorazepam; Male; Premedication; Psychoses, Substan | 2003 |
Revisiting cycloid psychosis: a case of an acute, transient and recurring psychotic disorder.
Topics: Acute Disease; Aged; Benzodiazepines; Cognition Disorders; Delusions; Diagnosis, Differential; Diagn | 2006 |
[Epilepsy: which therapy in acute care?].
Topics: Acute Disease; Anticonvulsants; Benzodiazepines; Clobazam; Clonazepam; Diazepam; Epilepsy; Humans; L | 2006 |
Anticholinergic drug-induced delirium in an elderly Alzheimer's dementia patient.
Topics: Acute Disease; Aged, 80 and over; Alzheimer Disease; Amitriptyline; Antipsychotic Agents; Cholinergi | 2007 |
[Agitation and hallucinations during acute lorazepam poisoning in children. Apropos of 65 personal cases].
Topics: Acute Disease; Adolescent; Akathisia, Drug-Induced; Child; Child, Preschool; Female; Gastric Lavage; | 1984 |
[Benzodiazepine monotherapy in acute schizophrenia].
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Diazepam; Humans; Lorazepam; Male; Schizophrenia; Schizop | 1994 |
Increase of serum creatine phosphokinase in catatonia: an investigation in 32 acute catatonic patients.
Topics: Acute Disease; Adult; Antipsychotic Agents; Catatonia; Combined Modality Therapy; Creatine Kinase; D | 1996 |
Reduced activation and altered laterality in two neuroleptic-naive catatonic patients during a motor task in functional MRI.
Topics: Acute Disease; Adult; Arousal; Brain Mapping; Dominance, Cerebral; Female; Humans; Injections, Intra | 1999 |
Management of acute psychosis.
Topics: Acute Disease; Benzodiazepines; Health Services Accessibility; Humans; Injections, Intramuscular; Lo | 2000 |
Brief acute psychosis following hysterectomy in ethnopsychiatric context.
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety Disorders; China; Culture; | 2000 |
Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation.
Topics: Acute Disease; Administration, Oral; Adult; Antipsychotic Agents; Drug Therapy, Combination; Emergen | 2001 |
Bayesian pharmacokinetics of lithium after an acute self-intoxication and subsequent haemodialysis: a case report.
Topics: Acute Disease; Acute Kidney Injury; Adult; Antimanic Agents; Antipsychotic Agents; Bayes Theorem; Bi | 2002 |
Effects of aging and liver disease on disposition of lorazepam.
Topics: Acute Disease; Adult; Aging; Anti-Anxiety Agents; Female; Hepatitis, Viral, Human; Humans; Kinetics; | 1978 |
Intramuscular/oral lorazepam in acute alcohol withdrawal and incipient delirium tremens.
Topics: Acute Disease; Adult; Alcohol Withdrawal Delirium; Alcoholism; Anti-Anxiety Agents; Female; Humans; | 1979 |
Acute therapeutic modalities for experimental vasogenic edema.
Topics: Acetazolamide; Acute Disease; Animals; Brain Edema; Cerebrovascular Disorders; Cold Temperature; Dex | 1979 |
Strange attractors, chaotic behavior and informational aspects of sleep EEG data.
Topics: Acute Disease; Adult; Algorithms; Electrodes; Electroencephalography; Female; Humans; Lorazepam; Mal | 1992 |
Acute and delayed emesis after cisplatin-based regimen: description and prevention.
Topics: Acute Disease; Antiemetics; Cisplatin; Dexamethasone; Dose-Response Relationship, Drug; Humans; Lora | 1991 |
Lorazepam in the treatment of acute conversion disorder.
Topics: Acute Disease; Adult; Conversion Disorder; Humans; Hypnosis; Lorazepam; Male | 1990 |
Gilles de la Tourette's syndrome. Amelioration following acute akinesia during lorazepam withdrawal.
Topics: Acute Disease; Humans; Lorazepam; Male; Middle Aged; Paralysis; Substance Withdrawal Syndrome; Toure | 1989 |
Acute treatment of manic agitation with lorazepam.
Topics: Acute Disease; Bipolar Disorder; Humans; Injections, Intramuscular; Lorazepam; Psychomotor Agitation | 1986 |